This is a translation of the Swedish press release published 2022-12-01

Neola Medical AB (publ) will participate at ABG Sundal Collier’s Investor Day in Stockholm the 6th of December and present the company. CEO Hanna Sjöström will present the company at 14.15 (2.15 pm) CET. Following the presentation there will be a shorter Q&A moderated by an ABGSC-analyst.

ABGSC’s Investor Day is a quarterly recurring seminar where investors get the opportunity to learn more about selected companies covered by ABGSCs sponsored research. Also a few selected companies with innovative business models participate in the event.

“I look forward to presenting at ABGSC’s Investor Day in December. We have had an intensive fall with both a preferential rights issue and certification of our quality management system according to ISO 13485. We are now in a phase with focus on the regulatory work before market approval in both EU and the U.S., and aiming for the market launch of Neola®.”, says Hanna Sjöström, CEO at Neola Medical.

The presentation will also be livestreamed, and available at the following link:

Read the entire press release (in Swedish) here: Press release

Read the entire translation of the Swedish press release here: Press communication